Notice for pemigatinib (Incyte Biosciences Australia Pty Ltd)
Active ingredients
pemigatinib
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Immediate-release tablet
Indication
For the treatment of cholangiocarcinoma
Therapeutic area
Oncology